Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

Gustave Roussy inaugure MyCare, une structure unique et innovante entièrement dédiée aux soins de support et à leur évaluation scientifique

back to job offer list
back to clinical trials

Villejuif, 25 septembre 2024

Label Newsweek
09/23/2024

Gustave Roussy, the first cancer research and treatment center in France and Europe, maintains its position in the top 5 hospitals for oncology globally

For the fifth consecutive year, Newsweek magazine has ranked Gustave Roussy among the top five hospitals for oncology worldwide, highlighting its outstanding performance in both patient care and research.
papillomavirus
09/22/2024

Cancers gynécologiques et ORL : pourquoi la lutte contre les papillomavirus est-elle cruciale ?

À l’occasion de Septembre Turquoise et de la campagne Make Sens "Prendre le cancer à la gorge", deux campagnes de prévention et de sensibilisation respectivement consacrées aux cancers gynécologiques et aux cancers ORL, Gustave Roussy rappelle son engagement contre les papillomavirus humains, responsable de nombreux cas dans ces deux pathologies....

Réplication du génome et de l’épigénome - Team members

back to job offer list
back to clinical trials

(Epi)genome replication : team members

  • Nataliya Petryk (CRCN CNRS) ORCID: 0000-0001-8629-1475
  • Nora Fajri (research engineer, IGR)
  • Oxana Zhironkina (post-doctoral fellow, IGR)
  • Antoine Pigeon (Ph. D. student Paris-Saclay)

Alumni : Pauline Potisek (Pharmacie student, Paris Saclay), Alexis Esteves (Master 2 Sorbonne-University).

We are seeking motivated students and post-doctoral fellows to join our team. Please contact us at nataliya.petryk@gustaveroussy.fr

ESMO 2024 - personalised treatments for soft tissue sarcomas

back to job offer list
back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 16 September 2024

ESMO 2024 - Radiation therapy for women with breast cancer will now last for no more than three weeks

back to job offer list
back to clinical trials

ESMO 2024 – Presidential Symposium

Villejuif, 15 September 2024

ESMO 2024 - Metastatic lung cancer: new therapeutic avenues are opening up thanks to the identification of resistance to targeted treatments

back to job offer list
back to clinical trials

ESMO 2024 - Proffered Paper Session

Villejuif, 14 September 2024

ESMO 2024 - A new medically promising antibody conjugate for metastatic breast cancer

back to job offer list
back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 13 September 2024

ESMO 2024 - New hope in the treatment of thymus gland cancers

back to job offer list
back to clinical trials

ESMO 2024 – Proffered Paper Session

Villejuif, 13 September 2024

09/11/2024

Gustave Roussy at ESMO Congress 2024

Bringing together more than 31,000 international experts, the European Society of Medical Oncology (ESMO) annual congress is one of the highlights of global oncology. This year, it will be held from 13 to 17 September in Barcelona. Gustave Roussy, the leading cancer research and treatment centre in France and Europe, ranked fourth globally, is one...

Pages